Things are looking bleak and no amount of rosy colored...
Nov 9, 2015 15:37:21 GMT -5
jpg, Chris-C, and 2 more like this
Post by EveningOfTheDay on Nov 9, 2015 15:37:21 GMT -5
eyeglasses can change that.
At some point, we will have to accept that all those Mannkind detractors had it right, if not in the ultimate fate of Mannkind, which is something that has not been determined yet, yes in the timing for the share price. To me it is of little consolation that Afrezza works so well, small validation at this point, or that this was pure manipulation, or any other excuses.
Those that predicted that Afrezza would remain a niche drug and that Mannkind might be running out of money by year's end were simply right. The fact that, as some claim, they are really so powerful as to be able to create their own reality, makes little difference to me or, I am guessing, to anybody else in this board, at this point. The fact that I got it completely wrong does make a pretty big difference.
Time will tell if things will turn around for Mannkind or not, but I think it is time to start recognizing that the lack of information, the insider sales, the negatives articles and ratings might have been based in simple reality. Afrezza is great and the fact that is so great, so beautiful in its simplicity and efficiency is a testament to Mr. Mann's ingenuity, but infatuation, whether for a product or a stock, is never the way to go. I joined this board because it was a great place to obtain information on Mannkind, but as time has gone by, less and less info has been allowed to scape the circle of silence and more and more conjecture has taken over the board.
I will be listening to managements presentation in a few hours, but honestly expect no positive news. Brace yourselves. Of course this is my humble opinion.
At some point, we will have to accept that all those Mannkind detractors had it right, if not in the ultimate fate of Mannkind, which is something that has not been determined yet, yes in the timing for the share price. To me it is of little consolation that Afrezza works so well, small validation at this point, or that this was pure manipulation, or any other excuses.
Those that predicted that Afrezza would remain a niche drug and that Mannkind might be running out of money by year's end were simply right. The fact that, as some claim, they are really so powerful as to be able to create their own reality, makes little difference to me or, I am guessing, to anybody else in this board, at this point. The fact that I got it completely wrong does make a pretty big difference.
Time will tell if things will turn around for Mannkind or not, but I think it is time to start recognizing that the lack of information, the insider sales, the negatives articles and ratings might have been based in simple reality. Afrezza is great and the fact that is so great, so beautiful in its simplicity and efficiency is a testament to Mr. Mann's ingenuity, but infatuation, whether for a product or a stock, is never the way to go. I joined this board because it was a great place to obtain information on Mannkind, but as time has gone by, less and less info has been allowed to scape the circle of silence and more and more conjecture has taken over the board.
I will be listening to managements presentation in a few hours, but honestly expect no positive news. Brace yourselves. Of course this is my humble opinion.
